Business

Aclarion Announces Addition of Keck Medical Center of USC as CLARITY Trial Site

USC Spine Center, part of Keck Medicine of USC, specializes in treating complex spine conditions with the latest cutting-edge technologiesCLARITY is a randomized clinical trial designed to demonstrate Nociscan’s ability to improve surgical outcomes for chronic low back pain Nociscan aims to become the gold standard in identifying sources of low back pain through MR Spectroscopy (MRS) and Augmented Intelligence (AI) BROOMFIELD, Colo., May 20, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc., (“Aclarion” o

articleAclarion, Inc.May 20, 20254/company/aclarion-inc/news/aclarion-announces-addition-keck-medical-100000142
Aclarion Announces Addition of Keck Medical Center of USC as CLARITY Trial Site

About this update from Aclarion, Inc.

[{"type":"image","alt":"Aclarion, Inc.","displaySize":"","headline":null,"caption":"Aclarion, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":140,"height":83,"url":"https://media.zenfs.com/en/globenewswire.com/ba6de721dd8ef6e3bce232e051476ebf"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/JqjNbxSKpdl2ksI_nXtiLg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIxMDtoPTEyNTtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/ba6de721dd8ef6e3bce232e051476ebf","width":140,"height":83}},"lazy":false},{"type":"list","items":[{"val":[{"type":"text","content":"USC Spine Center, part of Keck Medicine of USC, specializes in treating complex spine conditions with the latest cutting-edge technologies","length":138,"tagName":"p"}]},{"val":[{"type":"text","content":"CLARITY is a randomized clinical trial designed to demonstrate Nociscan’s ability to improve surgical outcomes for chronic low back pain ","length":136,"tagName":"p"}]},{"val":[{"type":"text","content":"Nociscan aims to become the gold standard in identifying sources of low back pain through MR Spectroscopy (MRS) and Augmented Intelligence (AI)","length":143,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":417,"olType":false},{"type":"text","content":"BROOMFIELD, Colo., May 20, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low back pain, today announced the addition of Keck Medical Center of USC as a CLARITY (Chronic Low bAck pain Randomized Independent Trial studY) trial site. The pivotal CLARITY study is designed to demonstrate Nociscan’s clinical and economic value in spine surgery.","length":562,"tagName":"p"},{"type":"text","content":"“Keck Medicine of USC strives to offer patients access to new treatments and procedures, and tailored treatment options for all types of spine conditions – from simple to complex,” says Patrick Hsieh, MD, neurological spine surgeon with Keck Medicine of USC. “The USC Spine Center’s participation in the CLARITY trial demonstrates our commitment to deepening our understanding of spinal conditions to best serve patients’ specific care needs.”","length":443,"tagName":"p"},{"type":"text","content":"Keck Medicine of USC is the la...

More updates from Aclarion, Inc.

Keck Medicine of USCJohns Hopkins MedicineCLARITY trialKeck Medical Center of USCUSC Spine CenterCLARITYAclarion, IncCLARITYNorthwestern Medicinephysicianspatientsaugmented intelligence